The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza

Influenza and other Respiratory Viruses

Volumn 9, Issue S1, 2015, Pages 31-37

  Macias, Alejandro E ^a   Precioso, Alexander R ^b,c   Falsey, Ann R ^d  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Global Influenza Initiative; Influenza; Pregnancy; Pregnant women; Recommendations; Vaccination

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; PLACEBO; INACTIVATED VACCINE;

2009 H1N1 INFLUENZA; ANTIBODY TITER; ARTICLE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOGENICITY; INFANT MORTALITY; INFECTION PREVENTION; INFLUENZA VACCINATION; INJECTION SITE REACTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SEASONAL INFLUENZA; ADULT; FEMALE; HEALTH; INFLUENZA, HUMAN; NEWBORN; PANDEMICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEASON;

ADULT; FEMALE; GLOBAL HEALTH; HUMANS; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; SEASONS; VACCINES, INACTIVATED;

EID: 84938808651     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12320     Document Type: Article

References (60)

1. Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458.
2. Louie JK, Acosta M, Jamieson DJ, Honein MA, California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010; 362:27-35.
3. Steinhoff MC, MacDonald N, Pfeifer D, Muglia LJ. Influenza vaccine in pregnancy: policy and research strategies. Lancet 2014; 383:1611-1613.
4. Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011; 29:4439-4452.
5. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-1102.
6. Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-1564.
7. Adegbola R, Nesin M, Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012; 207(3 Suppl):S28-S32.
8. World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, April 2012 - conclusions and recommendations (seasonal influenza vaccine). Wkly Epidemiol Rec 2012; 87:201-216.
9. World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012; 87:461-476.
10. World Health Organization. Influenza vaccines: WHO position paper. Wkly Epidemiol Rec 2005; 80:277-288.
11. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013; 62:1-43.
12. Galvao TF, Silva MT, Zimmermann IR, Lopes LAB, Bernardo EF, Pereira MG. Influenza vaccination in pregnant women: a systematic review. ISRN Prev Med 2013; 2013:879493. doi: 10.5402/2013/879493.
13. Brown CM. Severe influenza A virus (H1N1) infection in pregnancy. Obstet Gynecol 2010; 115:412-414.
14. Creanga AA, Kamimoto L, Newsome K et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011; 204(6 Suppl 1):S38-S45.
15. Doyle TJ, Goodin K, Hamilton JJ. Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) illness in Florida, 2009-2010: a population-based cohort study. PLoS ONE 2013; 8:e79040.
16. Ersbøll AS, Hesselvig AB, Hedegaard M, Krebs L. [Pregnant women are known to be at increased risk of severe illness when exposed to influenza A (H1N1)]. Ugeskr Laeger 2012; 174:2920-2921.
17. Jamieson DJ, Rasmussen SA, Uyeki TM, Weinbaum C. Pandemic influenza and pregnancy revisited: lessons learned from 2009 pandemic influenza A (H1N1). Am J Obstet Gynecol 2011; 204(6 Suppl 1):S1-S3.
18. Siston AM, Rasmussen SA, Honein MA et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517-1525.
19. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006 Nov; 12:1638-1643.
20. Mertz D, Kim TH, Johnstone J et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347:f5061.
21. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med 2005; 33(10 Suppl):S390-S397.
22. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205:10-18.
23. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med 2014; 370:2212-2218.
24. Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1) - United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep 2011; 60:1193-1196.
25. Legge A, Dodds L, MacDonald NE, Scott J, McNeil S. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ 2014; 186:E157-E164.
26. Kharbanda EO, Vazquez-Benitez G, Lipkind H et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013; 122:659-667.
27. Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan. PLoS ONE 2013; 8:e62983.
28. Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005; 192:1098-1106.
29. Nordin JD, Kharbanda EO, Benitez GV et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013; 121:519-525.
30. Sheffield JS, Greer LG, Rogers VL et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 2012; 120:532-537.
31. Black SB, Shinefield HR, France EK et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004; 21:333-339.
32. Jackson LA, Patel SM, Swamy GK et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 204:854-863.
33. Moro PL, Broder K, Zheteyeva Y et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011; 204:146.e1-e7.
34. World Health Organization. Global Advisory Committee on Vaccine Safety, June 2012. Wkly Epidemiol Rec 2012; 87:277-288.
35. Madhi SA, Cutland CL, Kuwanda L et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918-931.
36. Pasternak B, Svanström H, Mølgaard-Nielsen D et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012; 308:165-174.
37. Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201:547-552.
38. Thompson WW, Price C, Goodson B et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007; 357:1281-1292.
39. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979; 140:141-146.
40. Steinhoff MC, Omer SB, Roy E et al. Influenza immunization in pregnancy - antibody responses in mothers and infants. N Engl J Med 2010; 362:1644-1646.
41. Sperling RS, Engel SM, Wallenstein S et al. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol 2012; 119:631-639.
42. Blanchard-Rohner G, Meier S, Bel M et al. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J 2013; 32:1374-1380.
43. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993; 168:647-656.
44. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980; 142:844-849.
45. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J 1987; 6:398-403.
46. Steinhoff MC, Omer SB. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol 2012; 207(3 Suppl):S21-S27.
47. Steinhoff MC, Omer SB, Roy E et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184:645-653.
48. Steinhoff MC, MacDonald NE. Influenza pandemics - pregnancy, pathogenesis, and perinatal outcomes. JAMA 2012; 308:184-185.
49. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51:1355-1361.
50. Thompson MG, Li DK, Shifflett P et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014; 58:449-457.
51. Eick AA, Uyeki TM, Klimov A et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165:104-111.
52. France EK, Smith-Ray R, McClure D et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med 2006; 160:1277-1283.
53. Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD Jr. Cost-effectiveness of universal influenza vaccination in a pregnant population. Obstet Gynecol 2006; 107:1323-1329.
54. Jit M, Cromer D, Baguelin M, Stowe J, Andrews N, Miller E. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010; 29:115-122.
55. Chocontá-Piraquive LA, Alvis Guzmán N, De la Hoz Restrepo F. [Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia]. Rev Panam Salud Publica 2012; 31:447-453.
56. Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis 2009; 49:1784-1792.
57. Myers ER, Misurski DA, Swamy GK. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol 2011; 204(6 Suppl 1):S128-S140.
58. Public Health Agency of Canada. Statement on seasonal influenza vaccine for 2013-2014. Can Commun Dis Rep 2013; 39:ACS-4.
59. Abu Raya B, Srugo I, Kessel A et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. Vaccine 2014; 32:5787-5793.
60. Tinoco JC, Pavia-Ruz N, Cruz-Valdez A et al. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial. Vaccine 2014; 32:1480-1487.